OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
53
Results
Show all
Save search
Copy query
Show results for
Unknown
(50)
Transcriptomics
(1)
Proteomics
(1)
Genomics
(1)
Organisms
Homo sapiens
(1)
Alphavirus
(1)
Anemia
(1)
Betaherpesvirinae
(1)
Brassica oleracea var. oleracea
(1)
Cowpox virus
(1)
Coxsackievirus
(1)
Cytomegalovirus
(1)
Dengue virus
(1)
EFO:0001352
(1)
Filoviridae
(1)
Hepatitis B virus
(1)
Human alphaherpesvirus 1
(1)
Human betaherpesvirus 5
(1)
Human immunodeficiency virus
(1)
Human immunodeficiency virus 1
(1)
Human immunodeficiency virus 2
(1)
Influenza A virus
(1)
Influenza C virus
(1)
Japanese encephalitis virus group
(1)
Lyssavirus rabies
(1)
Monkeypox virus
(1)
Orthopoxvirus
(1)
Orthopoxvirus vaccinia
(1)
Rattus
(1)
Staphylococcus aureus
(1)
Streptococcus pneumoniae
(1)
Tick-borne encephalitis virus
(1)
Viruses
(1)
West Nile virus
(1)
Organisms
Homo sapiens
(1)
Repository
geo
(1)
pride
(1)
ENA
(1)
Tissue
Kidney
(1)
Disease
Renal clear cell carcinoma
(1)
Technology Type
Mass Spectrometry
(1)
SWATH MS
(1)
First Public Date
2016
(1)
Release Date
2022
(9)
2024
(8)
2025
(6)
2023
(6)
2021
(5)
2020
(4)
2019
(4)
2017
(2)
2014
(2)
2018
(1)
2016
(1)
2015
(1)
2012
(1)
Lab affiliation
Masaryk University, Faculty of Science
(1)
Publication date
2016
(1)
2021
(1)
Tags
xref:PubMed:27279483
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC).
Not available
S-EPMC7827724
|
biostudies-literature
Cite
Tumor infiltrating B lymphocytes (TIBs) associate with poor clinical outcomes, unfavorable therapeutic benefit and immunosuppressive context in metastatic clear cell renal cell carcinoma (mccRCC) patients treated with anti-PD-1 antibody plus Axitinib.
Not available
S-EPMC11102881
|
biostudies-literature
Cite
The genomic landscape of metastatic clear-cell renal cell carcinoma and its prognostic value: a comprehensive analysis of a large real-world clinico-genomic database.
Not available
S-EPMC11876921
|
biostudies-literature
Cite
First-Line Treatments for Metastatic Clear Cell Renal Cell Carcinoma: An Ever-Enlarging Landscape.
Not available
S-EPMC8895741
|
biostudies-literature
Cite
Identification of a suitable qPCR reference gene in metastatic clear cell renal cell carcinoma.
Not available
S-EPMC4275580
|
biostudies-literature
Cite
Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma.
Not available
S-EPMC7714499
|
biostudies-literature
Cite
A multicentric, single arm, open-label, phase I/II study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer (PRadR).
Not available
S-EPMC10835868
|
biostudies-literature
Cite
Carbonic anhydrase 9 expression increases with vascular endothelial growth factor-targeted therapy and is predictive of outcome in metastatic clear cell renal cancer.
Not available
S-EPMC4410300
|
biostudies-literature
Cite
Enhanced efficacy of ipilimumab plus nivolumab in angiogenic subtypes of metastatic clear-cell renal cell carcinoma.
Not available
S-EPMC12062415
|
biostudies-literature
Cite
Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade.
Not available
S-EPMC9793646
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
